Utility of [18F]-FDG PET Imaging to Distinguish Malignant from Benign Intrapapillary Mucinous Neoplasms (IPMN)

An accurate, non-invasive method to identify malignant IPMN is needed, as endoscopic ultrasounds are invasive and operator-dependent. PET/CT is already being utilized in the utility, management, and follow-up surveillance of pancreatic adenocarcinoma. Therefore, we are hypothesizing that PET/CT will also be an effective method for distinguishing malignant from benign IPMN.

Specialty Area(s)

Pancreas